This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"

434 views
June 7, 2024

Chapters

Overview of Relapsed Hodgkin Lymphoma Treatment

00:00

Evolving Role of Brentuximab Vedotin

01:18

Salvage Regimens & PD-1 Therapy Efficacy

03:11

Comparing Salvage Regimens & Outcomes

08:28

Key Takeaways & Treatment Strategies

09:50

Comments 0
Login to view comments. Click here to Login